Hepatitis C vaccine - Innogenetics
Alternative Names: E1 vaccine - Innogenetics; HCV E1 vaccine - Innogenetics; INNO 101; InnoVac-C; INNOVAX-CLatest Information Update: 11 Sep 2007
Price :
$50 *
At a glance
- Originator Innogenetics
- Class Hepatitis C vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 07 Sep 2007 Discontinued - Phase-II for Hepatitis C in Belgium (IM)
- 07 Sep 2007 Discontinued - Phase-II for Hepatitis C in Europe (IM)
- 12 Jul 2005 Data presented at the 40th Annual Meeting of the European Association for the Study of the Liver (EASL-2005) have been added to the adverse events and Viral infections immunogenicity and therapeutic trials sections